The JI REI fellowship program has a structured, comprehensive, and intensive 3 - year postgraduate training format, covering both the clinical and laboratory aspects of reproductive endocrinology. This program is approved by the American Board of Obstetrics and Gynecology. Taking advantage of our large clinical and research faculty, this program provides both basic and clinical research experience, as well as intensive training in infertility, assisted reproduction techniques, and the full range of surgical treatment approaches.

These disorders which affect the reproductive tract include operative endoscopy, tubal reconstruction, congenital anomalies of the reproductive tract, and others. The program spans three continuous years, beginning on July 1 of each year. The first year consists of 95% clinical work and 5% lab and clinical investigation. The second year is comprised of 90% basic laboratory techniques, clinical and animal investigation, and 10% clinical reproductive endocrinology. The third year includes 80% clinical and basic research in the fellow's focused area and 20% in the clinic.

The following sections demonstrate the breadth and depth of the clinical and research training resources currently in place.
 

Reproductive Medicine Division

  • Oocyte freezing
  • Robotic surgery
  • In vitro oocyte maturation
  • Blastocyst culture / transfer
  • ICSI using frozen eggs
  • Preimplantation genetic diagnosis: new diagnostic modalities
  • Endometrial receptivity studies
  • Sperm function tests
  • Sperm apoptosis

Reproductive Science Division

  • Sperm function and physiology
  • Oocyte freezing and chromosomal analysis 
  • Gene regulation of the endometrium  
  • Biomarkers of embryo developmental potential

Contraceptive Research and Development

  • Large - scale research sponsored by the Agency for International Development targeted to develop new contraceptives.
    Note: The fellows have access to a full - time technician who is experienced in many laboratory methods, including molecular techniques as well as standard assay methods ( including RIA ).
  • Molecular mechanisms of endometrial bleeding
  • Phase l and Phase 2 clinical testing of new spermicides, microbicides, and virucidal compounds
  • New treatment modalities for endometriosis and menopause